Filed: 2/14/2024ACC: 0001389932-24-000004
📋 What this filing means
DAFNA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 76 equity positions with a total reported market value of $417.34M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
76
Positions
$417.34M
Total AUM (reported)
42.79M
Total Shares
Allocation by class
COM$246.28M59.0%
COM NEW$65.54M15.7%
ETF$57.14M13.7%
SPONSORED ADR$16.92M4.1%
COMMON STOCK$6.83M1.6%
SPONSORED ADS$5.90M1.4%
SPON ADR$5.29M1.3%
Portfolio Concentration
Top 3$100.55M24.1%
4–10$106.56M25.5%
11–25$114.52M27.4%
Rest$95.71M22.9%
Top 3 weight
24.1%
Top 10 weight
49.6%
Voting Authority Distribution
Total shares with voting rights: 42.79M
Sole
Full voting authority
42.79M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole76
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings76
Rows:
SPDR S&P BIOTECH ETF
SOLEShares484K
TypeSH
Market value$43.22M
10.36%
Sole
484K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares400K
TypeSH
Market value$33.40M
8.00%
Sole
400K
Shared
0.00
None
0.00
STEREOTAXIS INC
SOLEShares13.68M
TypeSH
Market value$23.94M
5.74%
Sole
13.68M
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares516.34K
TypeSH
Market value$18.37M
4.40%
Sole
516.34K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares742.57K
TypeSH
Market value$16.05M
3.85%
Sole
742.57K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares123.47K
TypeSH
Market value$15.55M
3.73%
Sole
123.47K
Shared
0.00
None
0.00
KARUNA THERAPEUTICS INC
SOLEShares48.15K
TypeSH
Market value$15.24M
3.65%
Sole
48.15K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares511.89K
TypeSH
Market value$14.68M
3.52%
Sole
511.89K
Shared
0.00
None
0.00
ISHARES NASDAQ BIOTECH INDX
SOLEShares102.50K
TypeSH
Market value$13.92M
3.34%
Sole
102.50K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares276.74K
TypeSH
Market value$12.75M
3.05%
Sole
276.74K
Shared
0.00
None
0.00
MERUS N V
SOLEShares454.87K
TypeSH
Market value$12.51M
3.00%
Sole
454.87K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares110.86K
TypeSH
Market value$10.23M
2.45%
Sole
110.86K
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares686.46K
TypeSH
Market value$10.02M
2.40%
Sole
686.46K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares72.61K
TypeSH
Market value$9.57M
2.29%
Sole
72.61K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares67.55K
TypeSH
Market value$8.38M
2.01%
Sole
67.55K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares601.03K
TypeSH
Market value$7.36M
1.76%
Sole
601.03K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares168.77K
TypeSH
Market value$7.22M
1.73%
Sole
168.77K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares492.68K
TypeSH
Market value$7.08M
1.70%
Sole
492.68K
Shared
0.00
None
0.00
MORPHIC HOLDING INC
SOLEShares231.75K
TypeSH
Market value$6.69M
1.60%
Sole
231.75K
Shared
0.00
None
0.00
TANDEM DIABETES CARE INC
SOLEShares220.71K
TypeSH
Market value$6.53M
1.56%
Sole
220.71K
Shared
0.00
None
0.00
AXOGEN INC
SOLEShares935.89K
TypeSH
Market value$6.39M
1.53%
Sole
935.89K
Shared
0.00
None
0.00
2SEVENTY BIO INC
SOLEShares1.45M
TypeSH
Market value$6.18M
1.48%
Sole
1.45M
Shared
0.00
None
0.00
IMMUNOGEN INC
SOLEShares193.66K
TypeSH
Market value$5.74M
1.38%
Sole
193.66K
Shared
0.00
None
0.00
SAGE THERAPEUTICS INC
SOLEShares245K
TypeSH
Market value$5.31M
1.27%
Sole
245K
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares130.18K
TypeSH
Market value$5.29M
1.27%
Sole
130.18K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P BIOTECH ETFSOLE | ETF | 484K | SH | $43.22M 10.36% | 484K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 400K | SH | $33.40M 8.00% | 400K | 0.00 | 0.00 |
STEREOTAXIS INCSOLE | COM NEW | 13.68M | SH | $23.94M 5.74% | 13.68M | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 516.34K | SH | $18.37M 4.40% | 516.34K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 742.57K | SH | $16.05M 3.85% | 742.57K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 123.47K | SH | $15.55M 3.73% | 123.47K | 0.00 | 0.00 |
KARUNA THERAPEUTICS INCSOLE | COM | 48.15K | SH | $15.24M 3.65% | 48.15K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 511.89K | SH | $14.68M 3.52% | 511.89K | 0.00 | 0.00 |
ISHARES NASDAQ BIOTECH INDXSOLE | ETF | 102.50K | SH | $13.92M 3.34% | 102.50K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 276.74K | SH | $12.75M 3.05% | 276.74K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 454.87K | SH | $12.51M 3.00% | 454.87K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 110.86K | SH | $10.23M 2.45% | 110.86K | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 686.46K | SH | $10.02M 2.40% | 686.46K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 72.61K | SH | $9.57M 2.29% | 72.61K | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 67.55K | SH | $8.38M 2.01% | 67.55K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 601.03K | SH | $7.36M 1.76% | 601.03K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 168.77K | SH | $7.22M 1.73% | 168.77K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 492.68K | SH | $7.08M 1.70% | 492.68K | 0.00 | 0.00 |
MORPHIC HOLDING INCSOLE | COM | 231.75K | SH | $6.69M 1.60% | 231.75K | 0.00 | 0.00 |
TANDEM DIABETES CARE INCSOLE | COM NEW | 220.71K | SH | $6.53M 1.56% | 220.71K | 0.00 | 0.00 |
AXOGEN INCSOLE | COM | 935.89K | SH | $6.39M 1.53% | 935.89K | 0.00 | 0.00 |
2SEVENTY BIO INCSOLE | COMMON STOCK | 1.45M | SH | $6.18M 1.48% | 1.45M | 0.00 | 0.00 |
IMMUNOGEN INCSOLE | COM | 193.66K | SH | $5.74M 1.38% | 193.66K | 0.00 | 0.00 |
SAGE THERAPEUTICS INCSOLE | COM | 245K | SH | $5.31M 1.27% | 245K | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 130.18K | SH | $5.29M 1.27% | 130.18K | 0.00 | 0.00 |
Page 1 of 4